Cynata Therapeutics Limited (ASX:CYP)

Cynata Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 16, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	37	53	22	52	72	71
Market Cap Growth	140.75%	136.00%	-56.47%	-28.71%	1.27%	-43.68%
Enterprise Value	27	42	6	25	47	66
Last Close Price	0.17	0.29	0.13	0.36	0.51	0.61
PS Ratio	21.43	22.88	13.57	6.64	46.80	10.19
PB Ratio	3.25	7.34	1.34	2.15	2.55	4.26
P/TBV Ratio	3.25	7.34	1.34	2.15	2.55	4.26
EV/Sales Ratio	15.39	18.06	3.65	3.19	30.68	9.35
Asset Turnover	0.13	0.17	0.07	0.28	0.07	0.47
Quick Ratio	7.78	5.39	7.30	9.23	16.71	19.81
Current Ratio	7.91	5.58	7.46	9.33	17.03	20.08
Return on Equity (ROE)	-74.53%	-81.37%	-70.17%	-20.81%	-34.05%	-26.22%
Return on Assets (ROA)	-44.37%	-46.70%	-40.86%	-13.42%	-19.85%	-14.72%
Return on Capital (ROIC)	-49.14%	-53.39%	-45.73%	-14.49%	-20.85%	-15.76%
Earnings Yield	-23.75%	-18.39%	-63.59%	-10.56%	-10.63%	-5.09%
Buyback Yield / Dilution	-11.56%	-23.80%	-1.27%	-9.85%	-24.80%	-4.60%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.